Results 91 to 100 of about 4,854 (137)
Some of the next articles are maybe not open access.
Oral Vasoconstrictors in Perennial Non‐Allergic Rhinitis
Allergy, 1982Nasal airway resistance and nasal symptoms were evaluated in patients with perennial non‐allergic rhinitis before and after vasoconstrictory drugs and placebo taken orally. The patients were partly selected; these suffering mainly from nasal obstruction being tested.
P, Broms, L, Malm
openaire +2 more sources
Emerging drugs for the treatment of perennial allergic rhinitis
Expert Opinion on Emerging Drugs, 2016Allergic rhinitis is a worldwide health problem, currently affecting up to 40% of the general population, and characterized by the following symptoms in a variable degree of severity and duration: nasal congestion/obstruction, rhinorrhea, itchy nose and/or eyes, and/or sneezing.
LICARI, AMELIA +5 more
openaire +3 more sources
Control of nasal obstruction in perennial allergic rhinitis
Current Opinion in Allergy and Clinical Immunology, 2004Nasal obstruction, the cardinal symptom of persistent (perennial) allergic rhinitis, is one of the most common symptoms encountered in primary care and in specialist clinics. It is difficult to quantify by clinical examination, and, hence, objective assessment of the nasal airway is critical to rhinologic research.
De-Yun, Wang +2 more
openaire +2 more sources
Eosinophil Cationic Protein in Perennial Allergic Rhinitis
Auris Nasus Larynx, 1995For a quantitative investigation of eosinophil activation in perennial allergic rhinitis, eosinophil cationic protein (ECP) concentrations were measured by a radioimmunoassay in serum, nasal secretions (ECPWN) and in the supernatant of these nasal secretions (ECPsup) obtained from normal subjects and allergic patients.
K, Hisamatsu +4 more
openaire +2 more sources
Allergic rhinitis: A perennial burden
Practice Nursing, 1996The seriousness of allergic rhinitis and its impact on patients' lives is grossly underestimated. Glenis Scadding discusses the new guidelines and how practice nurses can ease the burden.
openaire +1 more source
Non-Allergic Perennial Rhinitis
2018Non-infectious rhinitis can broadly be subdivided into two subclasses, allergic and non-allergic rhinitis, depending predominantly on whether or not an allergic aetiology is implicated. The term 'non-allergic rhinitis' is commonly applied to a diagnosis of any nasal condition in which the symptoms are identical to those seen in allergic rhinitis but an
Jameel Muzaffar, Shahzada K. Ahmed
openaire +1 more source
Evaluation of allergic etiology in perennial rhinitis.
Annals of allergy, 1985In 197 patients with perennial rhinitis, 49 patients (24.9%) were found to be allergic to perennial inhalant allergens, 37 patients (18.8%) allergic to seasonal allergens, 52 patients (26.4%) had food intolerance, 12 patients (6.6%) showed evidence of nasal infection, and in 46 patients (23.3%) etiology was undetermined.
E.A. Pastorello +7 more
openaire +2 more sources
Ebastine in perennial allergic rhinitis.
Annals of allergy, 1992Oral ebastine, 10 mg once daily for seven days, and placebo were compared as treatment for active perennial allergic rhinitis in 151 patients in a multicenter, randomized, double-blind trial. Ebastine treatment produced a significant reduction in the incidence and severity of most symptoms associated with perennial rhinitis. Tolerability was similar in
C, Picado Vallés +5 more
openaire +1 more source
Allergy, 1997
The currently available respiratory topical corticosteroids are all effective at reducing the nasal symptoms of itch, sneezing, rhinorrhoea and obstruction associated with allergic rhinitis. The mechanism of action of corticosteroids is related to their anti‐innammatory activities.
openaire +2 more sources
The currently available respiratory topical corticosteroids are all effective at reducing the nasal symptoms of itch, sneezing, rhinorrhoea and obstruction associated with allergic rhinitis. The mechanism of action of corticosteroids is related to their anti‐innammatory activities.
openaire +2 more sources
Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis
Journal of Allergy and Clinical Immunology, 2003The evidence base for the use of H1-antihistamines in the treatment of perennial allergic rhinitis is considerably smaller than it is in the treatment of seasonal allergic rhinitis.We hypothesized that desloratadine, a new, nonsedating selective H1-antihistamine, would be efficacious and safe in the treatment of perennial allergic rhinitis.In a ...
F Estelle R, Simons +2 more
openaire +2 more sources

